Quarterly report pursuant to Section 13 or 15(d)

Accrued and Other Current Liabilities

Accrued and Other Current Liabilities

9 Months Ended

Sep. 30, 2023

5. Accrued and Other Current Liabilities

Accrued and other current liabilities consist of the following as of September 30, 2023 and December 31, 2022 (in thousands):


	September 30, 2023		December 31, 2022
Accrued compensation costs	$	1,583	$	1,676
Accrued professional fees		928		970
Accrued research and development service fees		723		3,443
Accrued insurance and facilities operation expenses		207		252
Other accrued expenses		23		157
Total accrued and other current liabilities	$	3,464	$	6,498

In February 2023, the Company entered into a financing agreement for $0.9 million for a portion of the Company’s annual directors and officers insurance premiums. The balance is due in monthly installments over eight months with an annual interest rate of 6.25%. The remaining balance was $0.1 million as of September 30, 2023 and is included in accounts payable on the consolidated balance sheet.